Non-invasive and clinical aspects of individuals at risk for steatotic liver disease

Medicine and Dentistry

• Clinical Feature 100%
• Liver Disease 100%
• Non-Alcoholic Fatty Liver Disease 100%
• Morbid Obesity 80%
• Cognitive Defect 80%
• Liver Biopsy 60%
• Fatty Liver 60%
• Disease 40%
• Liver Cirrhosis 40%
• Homeostatic Model Assessment 40%
• Fibrosis 40%
• Elastography 40%
• Diagnosis 20%
• Biological Marker 20%
• Clinical Trial 20%
• Cross Sectional Study 20%
• Prevalence 20%
• Alcohol Consumption 20%
• Macrophage 20%
• Diagnostic Accuracy 20%
• Biopsy Technique 20%
• Biological Functions 20%
• Cognition 20%
• Focused Ion Beam 20%
• FibroScan 20%
• Stroop Test 20%
• Scar Tissue 20%
• Nonalcoholic Fatty Liver 20%
• Triggering Receptor Expressed on Myeloid Cells 2 20%
• Comorbidity 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Feature 100%
• Liver Disease 100%
• Cognitive Defect 100%
• Morbid Obesity 100%
• Fatty Liver 75%
• Disease 50%
• Inflammation 50%
• Fibrosis 50%
• Liver Cirrhosis 50%
• Nonalcoholic Fatty Liver 50%
• Prevalence 25%
• Cross-Sectional Study 25%
• Ethanol 25%
• Clinical Trial 25%
• Biological Marker 25%
• Disease Activity Score 25%
• Focused Ion Beam 25%
• Triggering Receptor Expressed on Myeloid Cells 2 25%
• Comorbidity 25%